Lisa Nichols
About
In The Last Decade
Lisa Nichols
15 papers receiving 983 citations
Peers
Comparison fields: 5 of 89
- Immunology 479
- Oncology 285
- Molecular Biology 255
- Immunology and Allergy 194
- Radiology, Nuclear Medicine and Imaging 175
Countries citing papers authored by Lisa Nichols
This map shows the geographic impact of Lisa Nichols's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Nichols with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Nichols more than expected).
Fields of papers citing papers by Lisa Nichols
This network shows the impact of papers produced by Lisa Nichols. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Nichols. The network helps show where Lisa Nichols may publish in the future.
Co-authorship network of co-authors of Lisa Nichols
This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Nichols. A scholar is included among the top collaborators of Lisa Nichols based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Nichols. Lisa Nichols is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 13 | |
| 3 | 107 | |
| 4 | 78 | |
| 5 | 17 | |
| 6 | 63 | |
| 7 | 92 | |
| 8 | 17 | |
| 9 | 123 | |
| 10 | 51 | |
| 11 | 45 | |
| 12 | Mast-Cell Stabilizing Effects of Olopatadine following Allergen Challenge in Humans | 5 |
| 13 | Evaluation Of EV131, A Histamine Binding Protein, In A Murine Model Of Allergic Conjunctivitis | 2 |
| 14 | A phase I/II open label study of the safety and efficacy of an anti-ICAM-1 (intercellular adhesion molecule-1; CD54) monoclonal antibody in early rheumatoid arthritis. | 108 |
| 15 | 58 | |
| 16 | 226 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.